Anavex Life Sciences Corp (AVXL)

[boi568]

I think that the problem of dosing compliance in the schizo trial is not going to be an issue if the expansion of the trial size, as I expect, will remain as inpatient populations where the medical staff makes sure the patients receive the drug.